Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | PLAAT3 | P53816 | 2/20 | 0.45 |
| ▸ | PLAAT5 | Q96KN8 | 2/20 | 0.45 |
| ▸ | PLAAT2 | Q9NWW9 | 2/20 | 0.45 |
| ▸ | PLAAT4 | Q9UL19 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.44 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Toluene SCHEMBL2589614 | 1.00 | TDP1 (0.65) | TDP1L3MBTL1LMNATSHRALOX12 | |
| Toluene SCHEMBL1350443 | 1.00 | TDP1 (0.65) | TDP1L3MBTL1LMNATSHRALOX12 | |
| Toluene SCHEMBL9501175 | 1.00 | TDP1 (0.65) | TDP1L3MBTL1LMNATSHRALOX12 | |
| Toluene SCHEMBL9412512 | 1.00 | TDP1 (0.65) | TDP1L3MBTL1LMNATSHRALOX12 | |
| Toluene SCHEMBL9787341 | 1.00 | TDP1 (0.65) | TDP1L3MBTL1LMNATSHRALOX12 | |
| Toluene SCHEMBL1120065 | 1.00 | TDP1 (0.65) | TDP1L3MBTL1LMNATSHRALOX12 | |
| Toluene SCHEMBL5494793 | 1.00 | TDP1 (0.65) | TDP1L3MBTL1LMNATSHRALOX12 | |
| Toluene SCHEMBL3692883 | 1.00 | TDP1 (0.65) | TDP1L3MBTL1LMNATSHRALOX12 | |
| Phenylethyl Alcohol SCHEMBL28099020 | 0.95 | TDP1 (0.73) | TDP1L3MBTL1LMNATSHRALOX12 | |
| Phenylethyl Alcohol SCHEMBL5675914 | 0.93 | TDP1 (0.76) | TDP1L3MBTL1LMNATSHRALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104058993-B | Photonasty diamines, polyamic acid or derivatives thereof, aligning agent for liquid crystal, liquid crystal orientation film and liquid crystal display cells | 捷恩智株式会社 | 2017-09-15 | — | — | CN | disclosed |
| US-9079872-B2 | Phenanthro[9, 10-B]furans for electronic applications | BASF SE (DE) | 2015-07-14 | — | — | US | disclosed |
| CN-104058993-A | Photosensitive Diamines, Polyamide Acid And Derivatives Thereof, Liquid Crystal Aligning Agents, Liquid Crystal Alignment Films And Liquid Crystal Display Devices | JNC PETROCHEMICAL CORP | 2014-09-24 | — | — | CN | disclosed |
| EP-2625171-B1 | PHENANTHRO[9,10-B]FURANS FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2014-07-30 | — | — | EP | disclosed |
| EP-2625171-A1 | PHENANTHRO[9,10-B]FURANS FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2013-08-14 | — | — | EP | disclosed |
| CN-103153974-A | Phenanthro [9,10-b ] furans for electronic applications | BASF SE | 2013-06-12 | — | — | CN | disclosed |
| US-20120095222-A1 | PHENANTHRO[9, 10-B]FURANS FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2012-04-19 | — | — | US | disclosed |
| WO-2012045710-A1 | PHENANTHRO[9,10-B]FURANS FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2012-04-12 | — | — | WO | disclosed |
| US-20050113370-A1 | Therapeutic substituted indazole derivatives | ASTRAZENECA AB (SE) | 2005-05-26 | — | — | US | disclosed |
| CN-1557797-A | Process for preparing bisphenol compounds with long side-chain | 延边大学 | 2004-12-29 | — | — | CN | disclosed |
| EP-1476432-A1 | THERAPEUTIC SUBSTITUTED INDAZOLE DERIVATIVES | AstraZeneca AB (SE) | 2004-11-17 | — | — | EP | disclosed |
| WO-2003068754-A1 | THERAPEUTIC SUBSTITUTED INDAZOLE DERIVATIVES | ASTRAZENECA AB (SE) | 2003-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120095222-A1 | PHENANTHRO[9, 10-B]FURANS FOR ELECTRONIC APPLICATIONS | P2RY10, P2RY11, P2RY12 | TDP1 1677/4885L3MBTL1 4549/4885LMNA 2662/4885 |
| US-20050113370-A1 | Therapeutic substituted indazole derivatives | NR4A3, CBR3, NR3C2 | TDP1 4550/4885L3MBTL1 3771/4885LMNA 4717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.